Arkolith/Insider Trading/SANA/Form 4

Harr Steve

President & CEO, DirectorSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Mar 10, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 9, 2026Tax withholding(F)12K$3.13$36K8.0M
Mar 9, 2026Tax withholding(F)13K$3.10$40K7.9M
Mar 7, 2026Option exercise(M)50K—$08.0M
Mar 6, 2026Option exercise(M)42K—$07.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2026Option exercise(M)50K—$0100K
Mar 6, 2026Option exercise(M)42K—$0125K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001627387-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML